Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030487 | SCV000053157 | uncertain | Maturity-onset diabetes of the young type 3 | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Uncertain significance. |
Prevention |
RCV000242135 | SCV000305104 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000242135 | SCV000513247 | likely benign | not specified | 2015-12-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001511166 | SCV001718364 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000242135 | SCV001880075 | benign | not specified | 2021-03-24 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002463617 | SCV002605151 | benign | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs193922586 with MODY3. |